CDP Capital Technology Ventures is a Quebec-based investment firm that aims to develop new technology-based companies.
CDP Capital-Technology Ventures is out of business. CDP Capital-Technology Ventures is a principle investment firm specializing in building new technology-based companies. The firm seeks to invest in pre-startup and startup, research and development, mergers & acquisitions, expansion into new markets, and management buyouts. The firm also raises fund of funds that invest in North American and European venture capital funds. The firm seeks to invest in companies engaged in life sciences such as including biotechnology, pharmaceuticals, medical instrumentation; information technology; energy technologies; industrial technologies such as aeronautical and environmental. It also seeks to invest in communication and storage. CDP Capital-Technology Ventures was launched in 1995 and is an operating subsidiary of CDP Capital – Private Equity.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 29, 2009
Innodia
|
Series Unknown | $3M | Biotechnology | — |
Jul 12, 2007
TargeGen
|
Series D | $40M | Biopharma | — |
Mar 7, 2007
PainCeptor Pharma
|
Series B | $24.40M | Medical | — |
Dec 1, 2006
Xanthus Pharmaceuticals
|
Series B | $25M | Biopharma | — |
May 9, 2005
Entrisphere
|
Series C | $75M | Internet | — |
CDP Capital Technology Ventures has had 10 exits. CDP Capital Technology Ventures most notable exits include TransMedics , CymaBay Therapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
May 1, 2019 | TransMedics | IPO | Health Care | Detail |
Jul 18, 2014 | CymaBay Therapeutics | IPO | Biopharma | Detail |
May 17, 2011 | SiGe Semiconductor | M&A | Consumer Electronics | Detail |
Feb 2, 2011 | NeoPhotonics | M&A | Communications Infrastructure | Detail |
Jun 30, 2010 | TargeGen | M&A | Biopharma | Detail |